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1. Introduction 
Reactive oxygen species, ionizing radiation and alkylating agents can attack on DNA 
resulting in single or double strand breaks, generation of abasic sites, base and sugar lesions 
[1]. Double-strand breaks (ds breaks) are repaired by two different types of mechanism. One 
type takes advantage of proteins that promote homologous recombination (HR) to obtain 
instructions from the sister or homologous chromosome for proper repair of breaks. The 
other type permits joining of ends even if there is no sequence similarity between them. The 
latter process is called non-homologous end joining (NHEJ).The process by which complex 
single-strand breaks (those that cannot be directly religated) are repaired (SSBR) in some 
ways resembles NHEJ. Here we shall mainly discuss the mechanism of base excision repair 
(BER) of SSBR. 
2. Base excision DNA repair 
The major pathway to remove damaged DNA bases is Base Excision Repair (BER, Fig. 1). 
BER can be divided into five steps: (i) excision of damaged base by the specific DNA 
glycosylase and formation of apurinic/apyrimidinic (AP) site; (ii) cleavage of 
phosphodiester bond at AP site by AP-endonuclease or AP-lyase; (iii) removal of chemical 
groups interfering with gap filling and ligation; (iv) gap filling; (v) ligation [2]. 
The first step of the BER pathway is recognition of damaged base by the specific DNA 
glycosylase, which cleaves N-glycosidic bond leaving behind a free base and an AP site. In 
humans about 10 DNA glycosylases of different, but partially overlapping substrate 
specificities are known [3]. Some of them are bifunctional enzymes, which have endowed 
AP-lyase activity and cleave phosphodiester bonds at 3’ side of AP site either by ß- or ß/δ - 
elimination. E. coli endonuclease III (Nth), its human homolog, hNTH1 and human 8-oxoG 
DNA glycosylase (OGG1) catalyse reaction of ß- elimination, which creates alpha/ß-
unsaturated aldehyde (3’dRP) at the 3’ end of cleaved DNA strand. Bacterial 
formamidopyrimidine DNA glycosylase (Fpg), endonuclease VIII (Nei) and two human 
homologs of the latter, NEIL1 and NEIL2 catalyse ß/ δ-elimination and remove deoxyribose 
residue leaving phosphate at the 3’ end of cleaved DNA strand. Monofunctional DNA 
glycosylases need the assistance of AP-endonucleases, which hydrolyse phosphodiester 
bond at the 5’ end of the AP site. This yields DNA single strand break (SSB) with the 5’end 
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bearing baseless deoxyribose (5’dRP) and the 3’ end with the free hydroxyl group. Both AP 
sites and SSBs can be formed due to spontaneous hydrolysis of purines, as well as upon 
DNA damaging agents, like ionizing radiation or oxidation.  
 
 
Fig. 1. Base Excision Repair pathway 
Before filling the gap by DNA polymerases possible additional chemical groups present on 
3’OH end, which may block polymerisation, must be removed. Bacterial enzymes Xth 
(exonuclease III) and Nfo (Endonuclease IV), besides of cleaving phosphodiester bonds at 5’ 
AP-site, have as well 3’ phosphatase and 3’ phosphodiesterase activities and remove 
phosphates and phosphoglycolates from 3’ hydroxyl group of cleaved DNA strand[4]. In 
contrast, the major mammalian AP-endonuclease, APE1 effciently removes 3’ 
phosphoglycolate groups, but has a very weak 3’ phosphatase activity [5]. Phosphate groups 
left e.g. by NEIL1 glycosylase at 3’hydroxyls are most probably removed by polynucleotide 
kinase[6]. After cleavage of phosphodiester bond, repair may be continued on two 
alternative pathways (Fig. 1): short-patch BER (SP-BER) or long patch BER (LP-BER). During 
SP-BER in mammals, only one missing nucleotide is incorporated by DNA polymerase ß 
(pol ß), which has also endowed 5’dRPase activity and can remove baseless sugar from the 
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5’site of DNA break. In LP-BER a longer fragment ranging from 2 to 12 nucleotides is 
excised and re-synthesized [2]. Initially DNA polymerase elongates 3’ end by a few 
nucleotides and moves aside a DNA fragment which contains 5’ deoxyribophosphate. 
Subsequently, such flap structure is cleaved out by specific flap endonuclease, FEN1. It is 
believed that in LP-BER the first nucleotide is incorporated by DNA polymerase ß, while 
next ones by DNA polymerases δ or ε [2]. LP-BER demands also other assisting proteins, 
PCNA (proliferating cell nuclear antigen) and RPC (replication protein C). 
The last stage of BER is ligation of repaired DNA fragments by DNA ligase. Different DNA 
ligases(LIG) are operating in short and long patch BER, LIG1 in LP-BER and LIG3alpha in 
SP-BER. LIG3alpha remains in complex with XRCC1 (x-ray repair cross-complementing 
group 1) protein, which activates ligation of DNA ends by LIG3alpha. 
3. The role of XRCC1 protein in base excision DNA repair 
X-ray cross-complementing group 1 (XRCC1) is a 70- kDa protein comprising three 
functional domains; an N-terminal DNA binding domain, a centrally located BRCT I and a 
C-terminal BRCT II domain. It has no known enzymatic activity. Since it specifically 
interacts with nicked and gapped DNA in vitro[7-9], and rapidly and transiently responds to 
DNA damage in cells, it may serve as a strand-break sensor [10, 11].  
DNA single-strand breaks (SSBs) are one of the most frequent types of DNA damage in cells 
[12]. SSBs can lead to the accumulation of mutations or can be converted from single to 
cytotoxic double-strand breaks. Thus, SSBs pose a critical threat to the genetic stability and 
survival of cells[13]. Various proteins have been identified that are part of the repair 
machinery for SSBs, including XRCC1 protein. XRCC1 has been shown to be critically 
involved in DNA SSB repair in studies using XRCC1-mutant cells and XRCC1 knockout 
mice[14], which have increased sensitivity to alkylating agents, ultraviolet and ionizing 
radiation [15], as well as elevated levels of sister chromatic exchange. Since XRCC1 interacts 
with many proteins known to be involved in BER and SSBR, it has been proposed that 
XRCC1 functions as a scaffold protein able to coordinate and facilitate the steps of various 
DNA repair pathways[11, 16]. For example, XRCC1 interacts with several DNA glycosylases 
involved in repair of both oxidative and alkylated base lesions, and stimulates their 
activity[17, 18]. This protein interacts with DNA ligase III, polymerase beta and poly (ADP-
ribose) polymerase to participate in the base excision repair pathway. It is recruited to the 
site of DNA damage by several DNA glycosylases, e.g. OGG1 or NTH1 and remains at the 
site of repair till the last stage of ligation (Fig. 2), regulating and coordinating the whole 
process. XRCC1 facilitates exchange of DNA glycosylase with AP-endonuclease at the 
damaged substrate, which increases the excision rate of modified base, regulates pol ß 
interactions with APE1, and finally activates ligation step [17]. Binding of XRCC1 to 
Polynucleotide Kinase (PNK) enhances its capacity for damage discrimination, and binding 
of XRCC1 to DNA enables displacement of PNK from the phosphorylated product [19] thus 
accelerating SSBR of damaged DNA[20]. XRCC1 associates with Tyrosyl-DNA 
phosphodiesterase1(Tdp1) and enhances its activity required for repair of Top1-associated 
SSBs. It may act to recruit Tdp1 to these damaged sites[21]. Biochemical and nuclear 
magnetic resonance (NMR) experiments have demonstrated protein-protein interaction 
between the N-terminal domain of XRCC1 and the polymerase domain of pol ┚[22-25]. 
Additionally, stabilization of DNA ligase III┙ is dependent on its interaction with the BRCT 
II domain of XRCC1[26]. Aprataxin also interacts with XRCC1 and functions to maintain 
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XRCC1 stability, thus further linking the neurological degeneration associated with ataxia to 
an inefficiency of SSBR[27-29]. 
 
 
Fig. 2. Coordinative role of XRCC1 protein in BER 
Several additional proteins participate in BER and play regulative and coordinative role. 
The most important proteins are: PARP1 (polyADP ribose polymerase, which binds to free 
DNA ends and protects them against degradation, participates in chromatin relaxation and 
probably modulates binding of repair proteins to the site of damage by interaction with 
poly(ADP-ribose) chains [22, 30, 31], PCNA (proliferating cells nuclear antigen, DNA 
polymerase processivity subunit in LP-BER), RFC (replication factor C, loading PCNA on 
DNA), WRN (helicase deficient in Werner syndrome, a premature aging disease) or CSB 
(helicase deficient in Cockayne syndrome, neurodevelopmental and premature aging 
disease). 
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4. The role of E2F1 in XRCC1 associated base excision DNA repair 
E2F1 is a member of E2F family of transcription factors which plays an important role in 
promoting both cellular proliferation and cell death. E2F1 is important for regulating S-
phase specific genes as well as promoting apoptosis, just as other “activating” E2F family 
members [32, 33]. Simultaneously, E2F1 regulates DNA repair through interaction with 
other factors including RB family proteins, p53 and X-ray repair cross-complementing group 
1 (XRCC1) protein. 
4.1 E2F family 
The E2F transcription factor family consists of at least seven distinct genes divided into two 
groups. E2F1, E2F2, E2F3, E2F4, and E2F5 constitute one group, while the related DP1 and 
DP2 genes constitute the other group. Several forms of the DP2 (also referred to as DP3) 
protein can be produced as the result of alternative splicing, thus providing additional 
complexity to the E2F family. A functional E2F transcription factor consists of a heterodimer 
containing an E2F polypeptide and a DP polypeptide. Each of the five E2F polypeptides can 
heterodimerize with either DP1 or DP2 (DP3). Furthermore, each of these E2F/DP 
heterodimers (referred to as E2F factors hereafter) can bind consensus E2F sites in vitro and 
stimulate transcription when overexpressed[34].  
 
 
Fig. 3. the members of E2F 
All of the E2F subgroup proteins have a similar structure although E2F1, E2F2, and E2F3 are 
more closely related to each other than to E2F4 and E2F5 (Fig. 3). The DNA-binding domain 
found in the amino terminus represents the area of greatest homology between the five E2F 
species. Adjacent to the DNA-binding domain is the DP dimerization domain, which 
contains within it a leucine heptad repeat. The carboxy termini of the five E2F polypeptides 
contain the defined transcriptional activation domains, which are characterized by an 
abundance of acidic residues. Embedded within the transactivation domain of each E2F is a 
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region of homology involved in binding to the pocket proteins (Rb, p107, and p130). An 
additional region of homology, termed the Marked box, lies between the DP dimerization 
and transcriptional activation domains. Although this Marked box motif is highly conserved 
between the different E2Fs, its function is unknown. The amino termini of E2F1, E2F2, and 
E2F3 contain an additional region of homology not found in E2F4 or E2F5. This region has 
been demonstrated to have several functions, including binding to the cyclin A protein. The 
E2F4 protein contains a stretch of consecutive serine residues between the Marked box and 
the pocket protein binding domain not found in other E2F family members. DP1 and DP2 
polypeptides contain DNA-binding and dimerization domains related to the E2F proteins 
but do not contain transcriptional activation domains or regions homologous to the pocket 
protein binding or Marked box domains.  
An additional E2F family member has recently been isolated and termed EMA (E2F-binding 
site modulating activity) or E2F6[35, 36]. EMA/E2F6 shares homology with the E2F 
polypeptides in the DNA-binding domain, the DP dimerization domain and the Marked 
box, but lacks the pocket protein binding domain and acidic transcriptional activation 
domain found in the carboxy terminus of the other E2F species (figure 1). Like the other E2F 
polypeptides, EMA/E2F6 dimerizes with DP1 or DP2 and, in conjunction with a DP partner, 
binds E2F DNA-binding sites with preference for a subset of sites with the core sequence 
TCCCGCC. EMA/E2F6 appears to function as a repressor of E2F site-dependent 
transcription independent of pocket protein binding. The mechanism of repression is either 
through competitive inhibition with other E2F species or through an active transcriptional 
repression domain located in the amino terminus of EMA/E2F6.  
4.2 E2F factors and Rb family of pocket proteins 
The activity of E2F factors is regulated through association with the retinoblastoma tumor 
suppressor protein (Rb) and the other pocket proteins, p107 and p130. Binding of Rb, p107 
or p130 converts E2F factors from transcriptional activators to transcriptional repressors. 
The interplay among G1 cyclins (D-type cyclins and cyclin E), cyclin-dependent kinases 
(cdk4, 6, and 2), cdk inhibitors, and protein phosphatases determines the phosphorylation 
state of the pocket proteins which in turn regulates the ability of the pocket proteins to 
complex with E2F. E2F activity is further regulated through direct interactions with other 
factors, such cyclin A, Sp1, p53 and the ubiquitin-proteasome pathway. Deregulated 
expression of E2F family member genes has been shown to induce both inappropriate S 
phase entry and apoptosis. Experiments show that dimerization between E2F1 and its 
partner DP1 is stable and that E2F1 stimulates nuclear localization of DP1[37]. E2F1/DP1 is 
acetylated by the three acetyltransferases P300/CBP-associated factor (PCAF), cAMP-
response element-binding protein (CREBBP) and p300 which stabilizes E2F1 protein[38]. 
The acetylated complex is able to bind to PCAF to form an active dimer. The complex ability 
to bind to DNA on the promoter sites of its target genes along with its transcriptional 
activity are increased at the G1/S transition. During G2, the complex is phosphorylated by 
CycA2/CDK2[39]. The affinity between E2F1 and DP1 is then diminished leading to the 
dissociation of the complex and the release of PCAF[40]. The proteins undergo further 
modifications before degradation: E2F1 is deactelylated by histone deacetylase1(HDAC1) 
[41], dephosphorylated and phosphorylated de novo during S phase by Transcription factor 
II H (TFIIH) kinase for rapid degradation[42].  
Upon DNA damage, the complex PCAF/E2F1/DP1 can be phosphorylated and stabilized 
either by Checkpoint kinases (CHEK1 and CHEK2) through phosphorylation at Ser-364, or 
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by ataxia telangiectasia mutated(ATM) and ATR (ATM and Rad3-related) [43, 44], 
preventing E2F1 ubiquitination[45]. E2F1 mediates the transcription of many genes involved 
in apoptosis. However, E2F1 transcriptional activity can also be inhibited when bound to the 
topoisomerase TopBP1 in order to give time to the cell to repair the damage [46]. Mutations 
of the RB gene represent the most frequent molecular defect in Osteosarcoma. Studies in 
animal models and in human cancers have shown that deregulated E2F1 overexpression 
possesses either "oncogenic" or "oncosuppressor" properties, depending on the cellular 
context. High E2F1 levels exerted a growth-suppressing effect that relied on the integrity of 
the DNA damage response network. Surprisingly, induction of p73, an established E2F1 
target, was also DNA damage response-dependent. Furthermore, a global proteome 
analysis associated with bioinformatics revealed novel E2F1-regulated genes and potential 
E2F1-driven signaling networks that could provide useful targets in challenging this 
aggressive neoplasm by innovative therapies[47]. Similarly, deregulation of the Rb/E2F 
pathway in human fibroblasts results in an E2F1-mediated apoptosis dependent on ATM, 
Nijmegen breakage syndrome 1 (NBS1), CHEK2 and p53. E2F1 expression results in 
MRN(Mre11-Rad50-Nbs10 foci formation, which is independent of the Nbs1 interacting 
region and the DNA-binding domain of E2F1. E2F1-induced MRN foci are similar to 
irradiation-induced foci (IRIF) that result from double-strand DNA breaks because they 
correlate with 53BP1 and gammaH2AX foci, do not form in NBS cells, do form in AT cells 
and do not correlate with cell cycle entry. In fact, in human fibroblasts, deregulated E2F1 
causes a G1 arrest, blocking serum-induced cell cycle progression, in part through an 
Nbs1/53BP1/p53/p21(WAF1/CIP1) checkpoint pathway. This checkpoint protects against 
apoptosis because depletion of 53BP1 or p21(WAF1/CIP1) increases both the rate and extent 
of apoptosis. Nbs1 and p53 contribute to both checkpoint and apoptosis pathways. These 
results suggest that E2F1-induced foci generate a cell cycle checkpoint that, with sustained 
E2F1 activity, eventually yields to apoptosis. Uncontrolled proliferation due to Rb/E2F 
deregulation as well as inactivation of both checkpoint and apoptosis programs would then 
be required for transformation of normal cells to tumor cells[48]. ZBRK1 is a zinc finger-
containing transcriptional repressor that can modulate the expression of GADD45A, a DNA 
damage response gene, to induce cell cycle arrest in response to DNA damage. Liao et al 
found that the ZBRK1 promoter contains an authentic E2F-recognition sequence that 
specifically binds E2F1, but not E2F4 or E2F6, together with chromatin remodeling proteins 
CtIP and CtBP to form a repression complex that suppresses zinc finger protein (ZBRK1) 
transcription. Furthermore, loss of RB-mediated transcriptional repression led to an increase 
in ZBRK1 transcript levels, correlating with increased sensitivity to ultraviolet (UV) and 
methyl methanesulfonate-induced DNA damage. Thus, the RB.CtIP (CtBP interacting 
protein)/CtBP (C terminus-binding protein) /E2F1 complex plays a critical role in ZBRK1 
transcriptional repression, and loss of this repression may contribute to cellular sensitivity of 
DNA damage, ultimately leading to carcinogenesis[49]. One study suggested that E2F1 is 
also a transcriptional regulator of Xeroderma pigmentosum group C(XPC) and Rb/E2F1 
tumor suppressor pathway is involved in the regulation of the DNA lesion recognition step 
of nucleotide excision repair[50]. Disruption of pRB-E2F interactions by E1A is a key event 
in the adenoviral life cycle that drives expression of early viral transcription and induces cell 
cycle progression. This function of E1A is complicated by E2F1. pRB-E2F1 interactions are 
resistant to E1A-mediated disruption. Using mutant forms of pRB that selectively force E2F1 
to bind through only one of the two binding sites on pRB, E1A is unable to disrupt E2F1's 
unique interaction with pRB. Furthermore, analysis of pRB-E2F complexes during 
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adenoviral infection reveals the selective maintenance of pRB-E2F1 interactions despite the 
presence of E1A[51]. 
4.3 E2F1 factors and DNA repair 
The E2F1 transcription factor is post-translationally modified and stabilized in response to 
various forms of DNA damage to regulate the expression of cell cycle and pro-apoptotic 
genes. E2F1 also forms foci at DNA double-strand breaks (DSBs). The absence of E2F1 leads 
to spontaneous DNA breaks and impaired recovery following exposure to ionizing 
radiation. E2F1 deficiency results in defective NBS1 phosphorylation and foci formation in 
response to DSBs but does not affect NBS1 expression levels. Moreover, an increased 
association between NBS1 and E2F1 is observed in response to DNA damage, suggesting 
that E2F1 may promote NBS1 foci formation through a direct or indirect interaction at sites 
of DNA breaks. E2F1 deficiency also impairs RPA and Rad51 foci formation indicating that 
E2F1 is important for DNA end resection and the formation of single-stranded DNA at 
DSBs. These findings establish new roles for E2F1 in the DNA damage response, which may 
directly contribute to DNA repair and genome maintenance[52]. Chromatin structure is 
known to be a barrier to DNA repair and a large number of studies have now identified 
various factors that modify histones and remodel nucleosomes to facilitate repair. In 
response to ultraviolet (UV) radiation several histones are acetylated and this enhances the 
repair of DNA photoproducts by the nucleotide excision repair (NER) pathway. The E2F1 
transcription factor accumulates at sites of UV-induced DNA damage and directly 
stimulates NER through a non-transcriptional mechanism. E2F1 associates with the general 
control nonderepressible(GCN5) acetyltransferase in response to UV radiation and recruits 
GCN5 to sites of damage. UV radiation induces the acetylation of histone H3 lysine 9 
(H3K9) and this requires both GCN5 and E2F1. Moreover, as previously observed for E2F1, 
knock down of GCN5 results in impaired recruitment of NER factors to sites of damage and 
inefficient DNA repair. These findings demonstrate a direct role for GCN5 and E2F1 in NER 
involving H3K9 acetylation and increased accessibility to the NER machinery[53].  
Mice lacking E2F1 have increased levels of epidermal apoptosis compared to wild-type mice 
following exposure to ultraviolet B (UVB) radiation. Moreover, transgenic overexpression of 
E2F1 in basal layer keratinocytes suppresses apoptosis induced by UVB. Inhibition of UVB-
induced apoptosis by E2F1 is unexpected given that most studies have demonstrated a 
proapoptotic function for E2F1. E2F1-mediated suppression of apoptosis does not involve 
alterations in mitogen-activated protein kinase activation or B-cell lymphoma (Bcl-2) 
downregulation in response to UVB and is independent of p53. Instead, inhibition of UVB-
induced apoptosis by E2F1 correlates with a stimulation of DNA repair. Mice lacking E2F1 
are impaired for the removal of DNA photoproducts, while E2F1 transgenic mice repair 
UVB-induced DNA damage at an accelerated rate compared to wild-type mice. These 
findings suggest that E2F1 participates in the response to UVB by promoting DNA repair 
and suppressing apoptosis[54]. One study showed that E2F1 has a direct, non-
transcriptional role in DNA repair involving increased recruitment of NER factors to sites of 
damage[55]. 
4.4 The role of E2F1 in the regulation of XRCC1-dependent BER 
The exact mechanism of E2F1 regulating XRCC1-dependent base excision DNA repair is still 
not completely clear. The E2F1 pathway is centrally involved in the highly complex 
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networks coupling cellular proliferation and apoptosis. XRCC1, which plays a critical role in 
SSBR/BER [15], is a direct E2F1 target gene. E2F1 is upstream of XRCC1 significantly 
expands on prior observations that E2F plays a role in other repair pathways, such as MMR 
and NER [56-59]. The BER protein uracil-DNA glycosylase is also E2F-regulated[60]. 
Intriguingly, although E2F1 is best characterized as a transcription factor, E2F1 protein may 
have a direct role in DNA repair, as suggested by its localization to repair complexes[46, 61]. 
Thus, it is likely that multiple E2F-regulated mechanisms function in parallel with XRCC1 to 
stimulate repair. Chen found that enforced E2F expression stimulated XRCC1 levels and 
that(methylmethane sulfonate) MMS, which induces predominantly heat-labile DNA 
damage repaired by an XRCC1-mediated BER pathway[62, 63], causes an E2F1-dependent 
increase in XRCC1 expression. This is consistent with prior reports demonstrating that 
cellular stress increases endogenous XRCC1 levels [64-66], although this may be cell type-
specific [67]. How MMS-induced stress activates the E2F1-XRCC1 axis remains unknown. 
Cellular sensitivity to MMS may involve an ATR-dependent pathway, and genetic evidence 
suggests that MMS-induced damage activates the yeast Rad53 (Chk2 human homologue) 
pathway [68, 69]. 
Given that the ATM/ATR and Chk2 pathways phosphorylate and activate E2F1 protein[70-
73], it is possible that these kinases stimulate XRCC1 expression through E2F1 activation, 
although this remains to be demonstrated. Interestingly, Chk2-mediated stabilization of the 
FoxM1 transcription factor stimulates expression of DNA repair genes, including XRCC1 
[74]. Given that XRCC1 function is complex, it is likely that its control involves multiple 
levels. Indeed, posttranslational mechanisms modulate XRCC1 function, as evidenced by 
the ability of DNA-dependent protein kinase to phosphorylate XRCC1[75] as well as the 
requirement of protein kinase CK2 to phosphorylate XRCC1 and enhance SSBR and genetic 
stability [76]. Consistent with the complex control of XRCC1, serum starvation followed by 
refeeding stimulated XRCC1 expression. This is consistent with cell conditions of high E2F 
activity but also suggests that serum/mitogenic factors may be important too. This could be 
a cell typespecific phenomenon, since density arrest and release does not alter XRCC1 levels 
in human T24 cells[77]. Nevertheless, the biological importance of E2F1 regulation of 
XRCC1 is suggested by the attenuated in vivo DNA repair in E2F1-/-versus E2F1+/+MEFs. 
Two different methods demonstrated reduced DNA repair after MMS-induced DNA 
damage, which correlates with the decreased XRCC1 levels observed in E2F1-/-cells. The 
repair of MMS-damaged DNA still occurs in E2F1-/- cells, suggesting that the E2F1-XRCC1 
axis is not an absolute requirement in these systems. This is not surprising, given the 
complex and overlapping repair pathways involved. However, the significance of even a 
modestly reduced XRCC1-mediated repair function may have important implications for 
maintaining genomic stability and cell viability. Consistent with this notion of XRCC1 
mediating E2F1 activity is the observation that loss of XRCC1 function resulted in an 
enhanced E2F1-induced apoptotic response in EM9 cells compared with AA8 cells. 
Although E2F1 is a damage response protein, it also plays an important role in promoting 
the expression of a large number of genes required for replication and proliferation [57, 78-
80]. Given the intimate relationship between proliferation and replication/repair, the control 
of XRCC1 by E2F in undamaged cells further integrates SSBR with cell cycle progression as 
might be expected if enhanced SSBR were necessary to repair SSBs at replication forks [15, 
81-83]. Whether and in what context the other E2F family members play a role, as well as 
what specific SSBR pathways are utilized (e.g. long patch BER), remains to be explored. 
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Fig. 4. JWA-E2F1-XRCC1 regulation network in base excision repair 
The rapid response of XRCC1-dependent SSBR, especially in S/G2 phase, has been reported 
[81], and an increased co-localization of XRCC1 with proliferating cell nuclear antigen 
(PCNA) was observed at sites of replication during S-phase[84]. These results indicate the 
importance of XRCC1-dependent SSBR and its regulation during the cell cycle. 
Phosphorylation of E2F1 at serine-31 (S31) in response to DNA damage is required for the 
activation of ATM-, ATR-and ChK2-dependent DNA damage response pathways [44, 45, 85, 
86]. E2F1 has also been suggested to play a potential role in nucleotide excision repair 
pathway (NER)[54]. Recent reports have shown that XRCC1 is a direct target of E2F1 that is 
involved in the enhancement of SSBR and BER, which maintain genomic stability and 
contribute to cell survival[63]. Over-expression of E2F1 has been shown to induce quiescent 
cells to enter early S-phase and is capable of preventing cells from entering quiescence [87]. 
Recently, we showed that E2F1 regulates the expression of XRCC1 in response to activation 
of DNA repair processes, and the exact functional E2F1 binding sites in the XRCC1 
promoter region were identified[63]. Certain BER proteins, such as the uracil-DNA 
glycosylase, have also been demonstrated to be regulated by E2F transcription factors[60]. 
The fact that enhanced E2F expression stimulates XRCC1-mediated activation of the BER 
pathway in response to MMS-induced, heat-labile DNA damage suggests it might also be 
able to promote the expression of a variety of genes involved in DNA replication and cell 
proliferation.  
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The p53-E2F network controls and integrates critical functions, such as proliferation, cell 
cycle checkpoints, apoptosis, and DNA repair [43, 73, 88, 89]. In particular, p53 can promote 
BER [90, 91], and our discovery that E2F1 may also promote BER expands our 
understanding of the p53-E2F1 network in regulating DNA repair [63]. Disruption of these 
cooperative pathways has profound implications for tumorigenesis, as evidenced by 
enhanced tumor formation in knock-out mouse models for both p53 and E2F1, although 
intriguingly, both oncogenic and tumor suppressor functions for E2F1 are suggested in 
compound p53-/- and E2F1-/- mice [73, 92, 93].  
The JWA (ARL6IP5 )-E2F1-XRCC1 network also plays crucial role in base excision repair 
[94]. Exposure to oxidative stress increases the generation of intracellular reactive oxygen 
species, which stimulates NF1 binding to the JWA promoter, enhancing JWA transcription 
and translation. Then JWA regulates the expression of E2F1, leading to increased 
transcription of XRCC1. Interactions between JWA and XRCC1 occur in both the cytoplasm 
and the nucleus when the cells are subjected to oxidative stress (fig.4).. 
5. References  
[1] Tudek, B., et al., Modulation of oxidative DNA damage repair by the diet, inflammation and 
neoplastic transformation. J Physiol Pharmacol, 2006. 57 Suppl 7: p. 33-49 
[2] Fortini, P., et al., The base excision repair: mechanisms and its relevance for cancer susceptibility. 
Biochimie, 2003. 85(11): p. 1053-71 
[3] Wood, R.D., M. Mitchell, and T. Lindahl, Human DNA repair genes, 2005. Mutat Res, 2005. 
577(1-2): p. 275-83 
[4] Doetsch, P.W. and R.P. Cunningham, The enzymology of apurinic/apyrimidinic 
endonucleases. Mutat Res, 1990. 236(2-3): p. 173-201 
[5] Kelley, M.R. and S.H. Parsons, Redox regulation of the DNA repair function of the human AP 
endonuclease Ape1/ref-1. Antioxid Redox Signal, 2001. 3(4): p. 671-83 
[6] Wiederhold, L., et al., AP endonuclease-independent DNA base excision repair in human cells. 
Mol Cell, 2004. 15(2): p. 209-20 
[7] Marintchev, A., et al., Solution structure of the single-strand break repair protein XRCC1 N-
terminal domain. Nat Struct Biol, 1999. 6(9): p. 884-93 
[8] Mani, R.S., et al., Biophysical characterization of human XRCC1 and its binding to damaged and 
undamaged DNA. Biochemistry, 2004. 43(51): p. 16505-14 
[9] Horton, J.K., et al., XRCC1 and DNA polymerase beta in cellular protection against cytotoxic 
DNA single-strand breaks. Cell Res, 2008. 18(1): p. 48-63 
[10] Lan, L., et al., In situ analysis of repair processes for oxidative DNA damage in mammalian 
cells. Proc Natl Acad Sci U S A, 2004. 101(38): p. 13738-43 
[11] Mortusewicz, O. and H. Leonhardt, XRCC1 and PCNA are loading platforms with distinct 
kinetic properties and different capacities to respond to multiple DNA lesions. BMC Mol 
Biol, 2007. 8: p. 81 
[12] Lindahl, T., Instability and decay of the primary structure of DNA. Nature, 1993. 362(6422): 
p. 709-15 
[13] Slupphaug, G., B. Kavli, and H.E. Krokan, The interacting pathways for prevention and 
repair of oxidative DNA damage. Mutat Res, 2003. 531(1-2): p. 231-51 
[14] Tebbs, R.S., L.H. Thompson, and J.E. Cleaver, Rescue of Xrcc1 knockout mouse embryo 
lethality by transgene-complementation. DNA Repair (Amst), 2003. 2(12): p. 1405-17 
www.intechopen.com
 
DNA Repair 
 
138 
[15] Caldecott, K.W., XRCC1 and DNA strand break repair. DNA Repair (Amst), 2003. 2(9): p. 
955-69 
[16] Wong, H.K. and D.M. Wilson, 3rd, XRCC1 and DNA polymerase beta interaction 
contributes to cellular alkylating-agent resistance and single-strand break repair. J Cell 
Biochem, 2005. 95(4): p. 794-804 
[17] Marsin, S., et al., Role of XRCC1 in the coordination and stimulation of oxidative DNA damage 
repair initiated by the DNA glycosylase hOGG1. J Biol Chem, 2003. 278(45): p. 44068- 
74 
[18] Campalans, A., et al., XRCC1 interactions with multiple DNA glycosylases: a model for its 
recruitment to base excision repair. DNA Repair (Amst), 2005. 4(7): p. 826-35 
[19] Mani, R.S., et al., XRCC1 stimulates polynucleotide kinase by enhancing its damage 
discrimination and displacement from DNA repair intermediates. J Biol Chem, 2007. 
282(38): p. 28004-13 
[20] Whitehouse, C.J., et al., XRCC1 stimulates human polynucleotide kinase activity at damaged 
DNA termini and accelerates DNA single-strand break repair. Cell, 2001. 104(1): p. 107-
17 
[21] Plo, I., et al., Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of 
topoisomerase I-mediated DNA lesions. DNA Repair (Amst), 2003. 2(10): p. 1087- 
100 
[22] Caldecott, K.W., et al., XRCC1 polypeptide interacts with DNA polymerase beta and possibly 
poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in 
vitro. Nucleic Acids Res, 1996. 24(22): p. 4387-94 
[23] Kubota, Y., et al., Reconstitution of DNA base excision-repair with purified human proteins: 
interaction between DNA polymerase beta and the XRCC1 protein. EMBO J, 1996. 15(23): 
p. 6662-70 
[24] Marintchev, A., et al., Domain specific interaction in the XRCC1-DNA polymerase beta 
complex. Nucleic Acids Res, 2000. 28(10): p. 2049-59 
[25] Gryk, M.R., et al., Mapping of the interaction interface of DNA polymerase beta with XRCC1. 
Structure, 2002. 10(12): p. 1709-20 
[26] Taylor, R.M., et al., Role of a BRCT domain in the interaction of DNA ligase III-alpha with the 
DNA repair protein XRCC1. Curr Biol, 1998. 8(15): p. 877-80 
[27] Luo, H., et al., A new XRCC1-containing complex and its role in cellular survival of methyl 
methanesulfonate treatment. Mol Cell Biol, 2004. 24(19): p. 8356-65 
[28] Date, H., et al., The FHA domain of aprataxin interacts with the C-terminal region of XRCC1. 
Biochem Biophys Res Commun, 2004. 325(4): p. 1279-85 
[29] Clements, P.M., et al., The ataxia-oculomotor apraxia 1 gene product has a role distinct from 
ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. DNA 
Repair (Amst), 2004. 3(11): p. 1493-502 
[30] Schreiber, V., et al., Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base 
excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem, 2002. 
277(25): p. 23028-36 
[31] Leppard, J.B., et al., Physical and functional interaction between DNA ligase IIIalpha and 
poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair. Mol Cell Biol, 2003. 
23(16): p. 5919-27 
[32] Sears, R.C. and J.R. Nevins, Signaling networks that link cell proliferation and cell fate. J Biol 
Chem, 2002. 277(14): p. 11617-20 
www.intechopen.com
 
The Involvement of E2F1 in the Regulation of XRCC1-Dependent Base Excision DNA Repair 
 
139 
[33] Ginsberg, D., E2F1 pathways to apoptosis. FEBS Lett, 2002. 529(1): p. 122-5 
[34] Johnson, D.G. and R. Schneider-Broussard, Role of E2F in cell cycle control and cancer. 
Front Biosci, 1998. 3: p. d447-8 
[35] Morkel, M., et al., An E2F-like repressor of transcription. Nature, 1997. 390(6660): p. 567- 
8 
[36] Cartwright, P., et al., E2F-6: a novel member of the E2F family is an inhibitor of E2F-
dependent transcription. Oncogene, 1998. 17(5): p. 611-23 
[37] Magae, J., et al., Nuclear localization of DP and E2F transcription factors by heterodimeric 
partners and retinoblastoma protein family members. J Cell Sci, 1996. 109 ( Pt 7): p. 1717-
26 
[38] Frolov, M.V. and N.J. Dyson, Molecular mechanisms of E2F-dependent activation and pRB-
mediated repression. J Cell Sci, 2004. 117(Pt 11): p. 2173-81 
[39] He, Y. and W.D. Cress, E2F-3B is a physiological target of cyclin A. J Biol Chem, 2002. 
277(26): p. 23493-9 
[40] Tsantoulis, P.K. and V.G. Gorgoulis, Involvement of E2F transcription factor family in 
cancer. Eur J Cancer, 2005. 41(16): p. 2403-14 
[41] Martinez-Balbas, M.A., et al., Regulation of E2F1 activity by acetylation. EMBO J, 2000. 
19(4): p. 662-71 
[42] Ianari, A., et al., Specific role for p300/CREB-binding protein-associated factor activity in  
E2F1 stabilization in response to DNA damage. J Biol Chem, 2004. 279(29): p. 30830- 
5 
[43] Dimova, D.K. and N.J. Dyson, The E2F transcriptional network: old acquaintances with new 
faces. Oncogene, 2005. 24(17): p. 2810-26 
[44] Powers, J.T., et al., E2F1 uses the ATM signaling pathway to induce p53 and Chk2 
phosphorylation and apoptosis. Mol Cancer Res, 2004. 2(4): p. 203-14 
[45] Wang, B., et al., A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced 
apoptosis. J Biol Chem, 2004. 279(52): p. 54140-52 
[46] Liu, K., et al., Regulation of E2F1 by BRCT domain-containing protein TopBP1. Mol Cell 
Biol, 2003. 23(9): p. 3287-304 
[47] Liontos, M., et al., Modulation of the E2F1-driven cancer cell fate by the DNA damage 
response machinery and potential novel E2F1 targets in osteosarcomas. Am J Pathol, 2009. 
175(1): p. 376-91 
[48] Frame, F.M., et al., E2F1 induces MRN foci formation and a cell cycle checkpoint response in 
human fibroblasts. Oncogene, 2006. 25(23): p. 3258-66 
[49] Liao, C.C., et al., RB.E2F1 complex mediates DNA damage responses through transcriptional 
regulation of ZBRK1. J Biol Chem, 2010. 285(43): p. 33134-43 
[50] Lin, P.S., et al., The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion 
recognition step of nucleotide excision repair. DNA Repair (Amst), 2009. 8(7): p. 795- 
802 
[51] Seifried, L.A., et al., pRB-E2F1 complexes are resistant to adenovirus E1A-mediated 
disruption. J Virol, 2008. 82(9): p. 4511-20 
[52] Chen, J., et al., E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-
strand breaks. Cell Cycle, 2011. 10(8): p. 1287-94 
[53] Guo, R., et al., GCN5 and E2F1 stimulate nucleotide excision repair by promoting H3K9 
acetylation at sites of damage. Nucleic Acids Res, 2011. 39(4): p. 1390-7 
www.intechopen.com
 
DNA Repair 
 
140 
[54] Berton, T.R., et al., Regulation of epidermal apoptosis and DNA repair by E2F1 in response to 
ultraviolet B radiation. Oncogene, 2005. 24(15): p. 2449-60 
[55] Guo, R., et al., E2F1 localizes to sites of UV-induced DNA damage to enhance nucleotide 
excision repair. J Biol Chem, 2010. 285(25): p. 19308-15 
[56] Youn, C.K., et al., Bcl-2 expression suppresses mismatch repair activity through inhibition of 
E2F transcriptional activity. Nat Cell Biol, 2005. 7(2): p. 137-47 
[57] Polager, S., et al., E2Fs up-regulate expression of genes involved in DNA replication, DNA 
repair and mitosis. Oncogene, 2002. 21(3): p. 437-46 
[58] Bindra, R.S., et al., Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer 
Res, 2005. 65(24): p. 11597-604 
[59] Prost, S., et al., E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells. 
Oncogene, 2007. 26(24): p. 3572-81 
[60] Walsh, M.J., et al., E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, 
provide evidence for an autoregulatory mechanism for transcription. J Biol Chem, 1995. 
270(10): p. 5289-98 
[61] Maser, R.S., et al., Mre11 complex and DNA replication: linkage to E2F and sites of DNA 
synthesis. Mol Cell Biol, 2001. 21(17): p. 6006-16 
[62] Lundin, C., et al., Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no 
detectable in vivo DNA double-strand breaks. Nucleic Acids Res, 2005. 33(12): p. 3799-
811 
[63] Chen, D., et al., E2F1 regulates the base excision repair gene XRCC1 and promotes DNA 
repair. J Biol Chem, 2008. 283(22): p. 15381-9 
[64] Yacoub, A., et al., MAPK dependence of DNA damage repair: ionizing radiation and the 
induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human 
prostate carcinoma cells in a MEK1/2 dependent fashion. Int J Radiat Biol, 2001. 77(10): 
p. 1067-78 
[65] Yacoub, A., et al., Epidermal growth factor and ionizing radiation up-regulate the DNA repair 
genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK 
signaling. Radiat Res, 2003. 159(4): p. 439-52 
[66] Shung, B., J. Miyakoshi, and H. Takebe, X-ray-induced transcriptional activation  
of c-myc and XRCC1 genes in ataxia telangiectasia cells. Mutat Res, 1994. 307(1): p. 43-
51 
[67] Thompson, L.H. and M.G. West, XRCC1 keeps DNA from getting stranded. Mutat Res, 
2000. 459(1): p. 1-18 
[68] Libutti, S.K., et al., Parathyroid gland-specific deletion of the mouse Men1 gene results in 
parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res, 2003. 63(22): 
p. 8022-8 
[69] Nakada, D., et al., The ATM-related Tel1 protein of Saccharomyces cerevisiae controls a 
checkpoint response following phleomycin treatment. Nucleic Acids Res, 2003. 31(6): p. 
1715-24 
[70] Lin, W.C., F.T. Lin, and J.R. Nevins, Selective induction of E2F1 in response to DNA damage, 
mediated by ATM-dependent phosphorylation. Genes Dev, 2001. 15(14): p. 1833-44 
[71] Stevens, C., L. Smith, and N.B. La Thangue, Chk2 activates E2F-1 in response to DNA 
damage. Nat Cell Biol, 2003. 5(5): p. 401-9 
[72] Blattner, C., A. Sparks, and D. Lane, Transcription factor E2F-1 is upregulated in response to 
DNA damage in a manner analogous to that of p53. Mol Cell Biol, 1999. 19(5): p. 3704-13 
www.intechopen.com
 
The Involvement of E2F1 in the Regulation of XRCC1-Dependent Base Excision DNA Repair 
 
141 
[73] Stevens, C. and N.B. La Thangue, The emerging role of E2F-1 in the DNA damage response 
and checkpoint control. DNA Repair (Amst), 2004. 3(8-9): p. 1071-9 
[74] Tan, Y., P. Raychaudhuri, and R.H. Costa, Chk2 mediates stabilization of the FoxM1 
transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol, 2007. 
27(3): p. 1007-16 
[75] Levy, N., et al., XRCC1 is phosphorylated by DNA-dependent protein kinase in response to 
DNA damage. Nucleic Acids Res, 2006. 34(1): p. 32-41 
[76] Loizou, J.I., et al., The protein kinase CK2 facilitates repair of chromosomal DNA single-strand 
breaks. Cell, 2004. 117(1): p. 17-28 
[77] Dong, Z. and A.E. Tomkinson, ATM mediates oxidative stress-induced dephosphorylation of 
DNA ligase IIIalpha. Nucleic Acids Res, 2006. 34(20): p. 5721-279 
[78] Ishida, S., et al., Role for E2F in control of both DNA replication and mitotic functions as 
revealed from DNA microarray analysis. Mol Cell Biol, 2001. 21(14): p. 4684-99 
[79] Ren, B., et al., E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M 
checkpoints. Genes Dev, 2002. 16(2): p. 245-56 
[80] Weinmann, A.S., et al., Isolating human transcription factor targets by coupling chromatin 
immunoprecipitation and CpG island microarray analysis. Genes Dev, 2002. 16(2): p. 
235-44 
[81] Fan, J., et al., XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res, 
2004. 32(7): p. 2193-201 
[82] Moore, D.J., et al., Mutation of a BRCT domain selectively disrupts DNA single-strand break 
repair in noncycling Chinese hamster ovary cells. Proc Natl Acad Sci U S A, 2000. 
97(25): p. 13649-54 
[83] Taylor, R.M., A. Thistlethwaite, and K.W. Caldecott, Central role for the XRCC1 BRCT I 
domain in mammalian DNA single-strand break repair. Mol Cell Biol, 2002. 22(8): p. 
2556-63 
[84] Taylor, R.M., et al., A cell cycle-specific requirement for the XRCC1 BRCT II domain during 
mammalian DNA strand break repair. Mol Cell Biol, 2000. 20(2): p. 735-40 
[85] Inoue, Y., M. Kitagawa, and Y. Taya, Phosphorylation of pRB at Ser612 by Chk1/2 leads  
to a complex between pRB and E2F-1 after DNA damage. EMBO J, 2007. 26(8): p. 2083-
93 
[86] Pommier, Y., et al., Targeting chk2 kinase: molecular interaction maps and therapeutic 
rationale. Curr Pharm Des, 2005. 11(22): p. 2855-72 
[87] Kowalik, T.F., et al., E2F1 overexpression in quiescent fibroblasts leads to induction of cellular 
DNA synthesis and apoptosis. J Virol, 1995. 69(4): p. 2491-500 
[88] Harris, S.L. and A.J. Levine, The p53 pathway: positive and negative feedback loops. 
Oncogene, 2005. 24(17): p. 2899-908 
[89] Bell, L.A. and K.M. Ryan, Life and death decisions by E2F-1. Cell Death Differ, 2004. 11(2): 
p. 137-42 
[90] Sengupta, S. and C.C. Harris, p53: traffic cop at the crossroads of DNA repair and 
recombination. Nat Rev Mol Cell Biol, 2005. 6(1): p. 44-55 
[91] Adimoolam, S. and J.M. Ford, p53 and regulation of DNA damage recognition during 
nucleotide excision repair. DNA Repair (Amst), 2003. 2(9): p. 947-54 
[92] Yamasaki, L., et al., Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 1996. 
85(4): p. 537-48 
www.intechopen.com
 
DNA Repair 
 
142 
[93] Field, S.J., et al., E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 
1996. 85(4): p. 549-61 
[94] Wang, S., et al., JWA regulates XRCC1 and functions as a novel base excision repair protein in 
oxidative-stress-induced DNA single-strand breaks. Nucleic Acids Res, 2009. 37(6): p. 
1936-50 
www.intechopen.com
DNA Repair
Edited by Dr. Inna Kruman
ISBN 978-953-307-697-3
Hard cover, 636 pages
Publisher InTech
Published online 07, November, 2011
Published in print edition November, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The book consists of 31 chapters, divided into six parts. Each chapter is written by one or several experts in
the corresponding area. The scope of the book varies from the DNA damage response and DNA repair
mechanisms to evolutionary aspects of DNA repair, providing a snapshot of current understanding of the DNA
repair processes. A collection of articles presented by active and laboratory-based investigators provides a
clear understanding of the recent advances in the field of DNA repair.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Yulin Zhang and Dexi Chen (2011). The Involvement of E2F1 in the Regulation of XRCC1-Dependent Base
Excision DNA Repair, DNA Repair, Dr. Inna Kruman (Ed.), ISBN: 978-953-307-697-3, InTech, Available from:
http://www.intechopen.com/books/dna-repair/the-involvement-of-e2f1-in-the-regulation-of-xrcc1-dependent-
base-excision-dna-repair
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
